Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1989-11-8
pubmed:abstractText
The age- and dose-dependent effects of neonatal MSG were evaluated in pre- and postpubertal female rats. The neurotoxic action of MSG was assessed by examining monoamine content in microdissected regions of the mediobasal hypothalamus. MSG was administered at a dose of 4 mg/g on postnatal days 2 and 4 (MSG-Lo) or on postnatal days 2, 4, 6 and 8 (MSG-Hi). MSG-Hi treatment significantly reduced dopamine (DA) content in the arcuate nucleus (ANH) and lateral median eminence (LME) on postnatal day 21 when compared to NaCl-injected controls. DA content relative to controls was not altered in the ANH or LME postnatal or postnatal day 60 in MSG-Hi, however, norepinephrine (NE) was significantly (p less than 0.05) decreased on both postnatal day 21 and 60 in the LME. MSG-Lo treatment significantly (p less than 0.05) reduced ANH NE content on postnatal day 60 compared to controls. Both MSG-Hi and MSG-Lo treatment increased 5-hydroxyindoleacetic acid content in the preoptic area (POA) on postnatal day 60 relative to the controls. Developmental changes independent of MSG treatment were noted in the hypothalamus. DA and 3,4-dihydroxyphenylacetic acid (DOPAC) content in the POA were 2-3-fold higher on postnatal day 21 compared to postnatal day 60. In contrast, DA content increased with age in the ANH, LME and medial ME. NE content in the ANH increased as a function of age in controls, but not in MSG-treated rats. The effects of MSG treatment on the postnatal development and maturation of neurons in the mediobasal hypothalamus were discussed in relation to the direct neurotoxicity of MSG.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0892-0362
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
331-7
pubmed:dateRevised
2009-10-26
pubmed:meshHeading
pubmed-meshheading:2796887-3,4-Dihydroxyphenylacetic Acid, pubmed-meshheading:2796887-Aging, pubmed-meshheading:2796887-Animals, pubmed-meshheading:2796887-Animals, Newborn, pubmed-meshheading:2796887-Biogenic Monoamines, pubmed-meshheading:2796887-Brain Chemistry, pubmed-meshheading:2796887-Dopamine, pubmed-meshheading:2796887-Female, pubmed-meshheading:2796887-Glutamates, pubmed-meshheading:2796887-Homovanillic Acid, pubmed-meshheading:2796887-Male, pubmed-meshheading:2796887-Medulla Oblongata, pubmed-meshheading:2796887-Norepinephrine, pubmed-meshheading:2796887-Organ Size, pubmed-meshheading:2796887-Pons, pubmed-meshheading:2796887-Pregnancy, pubmed-meshheading:2796887-Preoptic Area, pubmed-meshheading:2796887-Rats, pubmed-meshheading:2796887-Rats, Inbred Strains, pubmed-meshheading:2796887-Sodium Glutamate
pubmed:articleTitle
Age- and dose-dependent effects of neonatal monosodium glutamate (MSG) administration to female rats.
pubmed:affiliation
Department of Pharmacodynamics, University of Florida, College of Pharmacy JHMHC, Gainesville 32610.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't